Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:13 AM
Ignite Modification Date:
2025-12-25 @ 2:13 AM
NCT ID:
NCT06567860
Eligibility Criteria:
Inclusion Criteria:
* Be between 18-64 years of age
* Males or non-pregnant, non-nursing females
* Weigh at least 85 pounds for whole blood draw
* Ability to provide signed informed consent
* Subjects must plan to receive the intramuscular influenza vaccine at the La Jolla Institute for Immunology
Exclusion Criteria:
* Received an influenza vaccine in the past year
* Infection with human immunodeficiency virus, hepatitis B virus, or hepatitis C virus
* History of certain anemias
* Presence of significant cardiovascular disease, systemic diseases including, but not limited to, diabetes which is not controlled, renal disease, liver disease, malignancy, infection, or blood clotting disorder
* Inability to provide informed consent
* Recent whole blood donation within 56 days or leukapheresis within 112 days
* Children (under 18 years of age), elderly (65 years of age or older), pregnant or nursing females
* Individuals with egg allergies
* Has ever had Guillain-Barré syndrome
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
64 Years
Study:
NCT06567860
Study Brief:
Protocol Section:
NCT06567860